Experience
Vifor (International) AG and American Regent, Inc.
Mylan Labs. Ltd. et al.
Represented Vifor and American Regent in two Hatch-Waxman Act cases against Mylan and Sandoz regarding their attempts to obtain FDA approval for their respective ANDAs directed to generic copies of Injectafer®. After a six-day bench trial, the cases resulted in a favorable settlement for our clients with a generic entry date well past the expiration of the composition patents.
Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al., 3:19-cv-13955, 3:19-cv-16305, D.N.J., Judges Wolfson, Arpert
American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al.
American Regent, Inc.
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.
BioDelivery Sciences International, Inc. et al.
Microchip Technology Incorporated v. Nuvoton Technology Corporation America et al.
Nuvoton Technology Corporation America et al.
Robert Bosch GmbH et al.
Biometric Technology Holdings LLC v. Iris ID Systems, Inc.
Iris ID Systems, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al.
Merck Sharp & Dohme LLC
BTG Inc., Ltd v. Actavis Labs FL Inc.; Amneal Pharms LLC
BTG Inc., Ltd.
Computer Sciences Corporation v. Tata Consultancy Services Limited et al.
Tata Consultancy Services Limited et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.